Metrics to compare | 4155 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4155PeersSector | |
|---|---|---|---|---|
P/E Ratio | 8.6x | 18.5x | −0.4x | |
PEG Ratio | 0.01 | 0.13 | 0.00 | |
Price/Book | 0.8x | 1.4x | 2.6x | |
Price / LTM Sales | 1.4x | 1.0x | 3.1x | |
Upside (Analyst Target) | - | 25.9% | 48.9% | |
Fair Value Upside | Unlock | 31.4% | 6.2% | Unlock |
OK Biotech Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of blood glucose monitoring systems and homecare healthcare devices in Taiwan, the rest of Asia, America, Africa, and Europe. The company offers nebulizers, blood glucose meters, glucometers, blood sugar meters, and blood glucose test strips. It also provides OTC hearing aids, multi-frequency therapy devices, and factory setup solutions, as well as professional OEM/ODM customized services. The company sells its products under the OKB and Prodigy brands. OK Biotech Co., Ltd. was incorporated in 2004 and is headquartered in Hsinchu City, Taiwan.